Associations between Interleukin-1 Gene Polymorphisms and Coronary Heart Disease Risk: A Meta-Analysis

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Zhou, Liang ^a   Cai, Jianguang ^a   Liu, Gang ^a   Wei, Yuan ^b   Tang, Hui ^a  

^a HUNAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Guangzhou Sport University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DNA POLYMORPHISM; EMBASE; FEMALE; GENE; GENE CLUSTER; GENETIC ASSOCIATION; HUMAN; IL 1 GENE; IL 1B 511 GENE; IL 1B+3954 GENE; IL 1RN GENE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDLINE; VARIABLE NUMBER OF TANDEM REPEAT;

CORONARY DISEASE; GENETIC HETEROGENEITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-1; POLYMORPHISM, GENETIC;

EID: 84866525323     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045641     Document Type: Article

References (55)

1. Global Atlas on cardiovascular disease prevention and control 2011. World Health Organization in collaboration with the World Heart Federation and the World Stroke Organization. WHO website. Available: http://whqlibdoc.who.int/publication/2011/9789241564373_eng.pdf. Accessed 2012 April 20.
2. Causes of death 2008: data sources and method. World Health Organization, Geneva. WHO website.Available:http://www.who.int/healthinfo/global_burden_disease/cod_2008_sources_methods.pdf. Accessed 2012 April 20.
3. Weber C, Noels H, (2011) Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17: 1410-1422.
4. Taube A, Schlich R, Sell H, Eckardt K, Eckel J (2012) Inflammation and Metabolic Dysfunction: Links to Cardiovascular Disease. Am J Physiol Heart Circ Physiol doi:10.1152/ajpheart.00907.2011.
5. Libby P, (2002) Inflammation in atherosclerosis. Nature 420: 868-874.
6. Buffon A, Biasucci LM, Liuzzo G, D'Onofrio G, Crea F, et al. (2002) Widespread coronary inflammation in unstable angina. N Engl J Med 347: 5-12.
7. Smith DE, Renshaw BR, Ketchem RR, Kubin M, Garka KE, et al. (2000) Four new members expand the interleukin-1 superfamily. J Biol Chem 275: 1169-1175.
8. Dinarello CA, (1996) Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147.
9. El-Omar EM, (2001) The importance of interleukin 1beta in Helicobacter pylori associated disease. Gut 48: 743-747.
10. Vamvakopoulos JE, Taylor CJ, Morris-Stiff GJ, Green C, Metcalfe S, (2002) The interleukin-1 receptor antagonist gene: a single-copy variant of the intron 2 variable number tandem repeat (VNTR) polymorphism. Eur J Immunogenet 29: 337-340.
11. Francis SE, Camp NJ, Dewberry RM, Gunn J, Syrris P, et al. (1999) Interleukin-1 receptor antagonist gene polymorphism and coronary artery disease. Circulation 99: 861-866.
12. Iacoviello L, Donati MB, Gattone M, (2000) Possible different involvement of interleukin-1 receptor antagonist gene polymorphism in coronary single vessel diseaseand myocardial infarction. Circulation 10: E193.
13. Zee RY, Lunze K, Lindpaintner K, Ridker PM, (2001) A prospective evaluation of the interleukin-1 receptor antagonist intron 2 gene polymorphism and the risk of myocardial infarction. Thromb Haemost 86: 1141-1143.
14. Vohnout B, Di Castelnuovo A, Trotta R, D'Orazi A, Panniteri G, et al. (2003) Interleukin-1 gene cluster polymorphisms and risk of coronary artery disease. Haematologica 88: 54-60.
15. Licastro F, Chiappelli M, Caldarera CM, Tampieri C, Nanni S, et al. (2004) The concomitant presence of polymorphic alleles of interleukin-1beta, interleukin-6 and apolipoprotein E is associated with an increased risk of myocardial infarction in elderly men. Results from a pilot study. Mech Ageing Dev 125: 575-579.
16. Iacoviello L, Di Castelnuovo A, Gattone M, Pezzini A, Assanelli D, et al. (2005) Polymorphisms of the interleukin-1beta gene affect the risk of myocardial infarction and ischemic stroke at young age and the response of mononuclear cells to stimulation in vitro. Arterioscler Thromb Vasc Biol 25: 222-227.
17. Zhang YM, Zhong LJ, He BX, Li WC, Nie J, et al. (2006) The correlation between polymorphism at position-511C/T in the promoter region of interleukin 1B and the severity of coronary heart disease. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 23: 86-88.
18. Kariz S, Milutinović A, Bregar D, Terzić I, Terzić R, et al. (2007) The interleukin-1 receptor antagonist gene and the inhibitor of kappa B-like protein gene polymorphisms are not associated with myocardial infarction in Slovene population with type 2 diabetes. Coll Antropol 31: 503-507.
19. Arman A, Soylu O, Yildirim A, Furman A, Ercelen N, et al. (2008) Interleukin-1 receptor antagonist gene VNTR polymorphism is associated with coronary artery disease. Arq Bras Cardiol 91: 293-298.
20. Geismar K, Enevold C, Sørensen LK, Gyntelberg F, Bendtzen K, et al. (2008) Involvement of interleukin-1 genotypes in the association of coronary heart disease with periodontitis. J Periodontol 79: 2322-2330.
21. Soylu O, Yildirim A, Coker A, Tezel T, List EO, et al. (2008) Interleukin-1B (-511) gene polymorphism is associated with acute coronary syndrome in the Turkish population. Eur Cytokine Netw 19: 42-48.
22. Zee RY, Hennessey H, Michaud SE, Ridker PM, (2008) Genetic variants within the interleukin-1 gene cluster, and risk of incident myocardial infarction, and ischemic stroke: a nested case-control approach. Atherosclerosis 201: 124-129.
23. Stein JM, Smeets R, Reichert S, Chrobot J, Fickl S, et al. (2009) The role of the composite interleukin-1 genotype in the association between periodontitis and acute myocardial infarction. J Periodontol 80: 1095-1102.
24. Zhu YH, Xu YC, Zhou B, Liang WB, Wang YY, et al. (2009) Association of interleukin-1B gene polymorphisms with coronary heart disease. Sichuan Da Xue Xue Bao Yi Xue Ban 40: 73-76.
25. Fragoso JM, Delgadillo H, Llorente L, Chuquiure E, Juárez-Cedillo T, et al. (2010) Interleukin 1 receptor antagonist polymorphisms are associated with the risk of developing acute coronary syndrome in Mexicans. Immunol Lett 133: 106-111.
26. Rios DL, Cerqueira CC, Bonfim-Silva R, Araújo LJ, Pereira JF, et al. (2010) Interleukin-1 beta and interleukin-6 gene polymorphism associations with angiographicallyassessed coronary artery disease in Brazilians. Cytokine 50: 292-296.
27. Coker A, Arman A, Soylu O, Tezel T, Yildirim A, (2011) Lack of association between IL-1 and IL-6 gene polymorphisms and myocardial infarction inTurkish population. Int J Immunogenet 38: 201-208.
28. Gora{ogonek}cy J, Gora{ogonek}cy I, Safranow K, Taryma O, Adler G, et al. (2011) Lack of association of interleukin-1 gene cluster polymorphisms with angiographically documented coronary artery disease: demonstration of association with hypertension in the Polish population. Arch Med Res 42: 426-432.
29. Zeybek U, Toptas B, Karaali ZE, Kendir M, Cakmakoglu B, (2011) Effect of TNF-α and IL-1β genetic variants on the development of myocardial infarction in Turkish population. Mol Biol Rep 38: 5453-5457.
30. Chen F, Cheng W, (2010) Correlation of IL-1beta-511 and IL-1RN VNTR gene polymorphism to coronary heart disease: a meta-analysis. Nan Fang Yi Ke Da Xue Xue Bao 30: 1635-1638.
31. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
32. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
33. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
34. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
35. Hackett TL, Stefanowicz D, Aminuddin F, Sin DD, Connett JE, et al. (2011) Effect of gene environment interactions on lung function and cardiovascular disease in COPD. Int J Chron Obstruct Pulmon Dis 6: 277-287.
36. Marculescu R, Endler G, Schillinger M, Iordanova N, Exner M, et al. (2002) Interleukin-1 receptor antagonist genotype is associated with coronary atherosclerosis in patients with type 2 diabetes. Diabetes 51: 3582-3585.
37. Momiyama Y, Hirano R, Taniguchi H, Nakamura H, Ohsuzu F, (2001) Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection. J Am Coll Cardiol 38: 712-717.
38. Kornman KS, Pankow J, Offenbacher S, Beck J, di Giovine F, et al. (1999) Interleukin-1 genotypes and the association between periodontitis and cardiovascular disease. J Periodontal Res 34: 353-357.
39. van Minkelen R, Wettinger SB, de Visser MC, Vos HL, Reitsma PH, et al. (2009) Haplotypes of the interleukin-1 receptor antagonist gene, interleukin-1 receptor antagonist mRNA levels and the risk of myocardial infarction. Atherosclerosis 203: 201-205.
40. Banerjee I, Pandey U, Hasan OM, Parihar R, Tripathi V, et al. (2009) Association between inflammatory gene polymorphisms and coronary artery disease in an Indian population. J Thromb Thrombolysis 27: 88-94.
41. Brown BD, Nsengimana J, Barrett JH, Lawrence RA, Steiner L, et al. (2010) An evaluation of inflammatory gene polymorphisms in sibships discordant for premature coronary artery disease: the GRACE-IMMUNE study. BMC Med 8: 5.
42. Auer J, Berent R, Weber T, Eber B, (2002) Interleukin-1 receptor antagonist gene polymorphism, infectious burden, and coronary artery disease. Clin Infect Dis 34: 1536-1537.
43. Keavney B, (2010) The interleukin-1 cluster, dyslipidaemia and risk of myocardial infarction. BMC Med 8: 6.
44. Momiyama Y, Ohmori R, Ohsuzu F, (2005) Association between IL-1beta gene polymorphism and myocardial infarction. Arterioscler Thromb Vasc Biol 25: e36.
45. Sims JE, Nicklin MJ, Bazan JF, Barton JL, Busfield SJ, et al. (2001) A new nomenclature for IL-1-family genes. Trends Immunol 22: 536-537.
46. Nicklin MJ, Barton JL, Nguyen M, FitzGerald MG, Duff GW, et al. (2002) A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 79: 718-725.
47. Ye F, Jin XQ, Chen GH, Den XL, Zheng YQ, et al. (2012) Polymorphisms of interleukin-1 and interleukin-6 genes on the risk of ischemic stroke in a meta-analysis. Gene: doi.org/10.1016/j.gene.2012.02.026.
48. Andreotti F, Porto I, Crea F, Maseri A, (2002) Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart 87: 107-112.
49. Kim HJ, Kim MY, Hwang JS, Kim HJ, Lee JH, et al. (2010) PPARdelta inhibits IL-1beta-stimulated proliferation and migration of vascular smooth muscle cells via up-regulation of IL-1Ra. Cell Mol Life Sci 67: 2119-2130.
50. Yang L, Guo XG, Du CQ, Yang JX, Jiang DM, et al. (2012) Interleukin-1 Beta Increases Activity of Human Endothelial Progenitor Cells: Involvement of PI3K-Akt Signaling Pathway. Inflammation: doi.org/10.1016/j.gene.2012.02.026.
51. Dinarello CA, (1991) Interleukin 1 and interleukin 1 receptor antagonism. Blood 77: 1627-1652.
52. Memon RA, Feingold KR, Moser AH, Fuller J, Grunfeld C, (1998) Regulation of fatty acid transport protein and fatty acid translocase mRNA levels by endotoxin and cytokines. Am J Physiol 274: E210-217.
53. Olofsson PS, Sheikine Y, Jatta K, Ghaderi M, Samnegård A, et al. (2009) A functional interleukin-1 receptor antagonist polymorphism influences atherosclerosis development. The interleukin-1beta:interleukin-1 receptor antagonist balance in atherosclerosis. Circ J 73: 1531-1536.
54. Santtila S, Savinainen K, Hurme M, (1998) Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1beta production in vitro. Scan J Immunol 47: 195e198.
55. Hurme M, Santtila S, (1998) IL-1 receptor antagonist (IL-1Ra) plasma levels are co-ordinately regulated by both IL-1Ra and IL-1beta genes. Eur J Immunol 28: 2598-2602.